Informed decision-making in colorectal cancer screening using colonoscopy or CT-colonography

Patient Education and Counseling

Volumn 91, Issue 3, 2013, Pages 318-325

  De Haan, Margriet C ^a   De Wijkerslooth, Thomas R ^a   Stoop, Esther ^b   Bossuyt, Patrick ^a   Fockens, Paul ^a   Thomeer, Maarten ^b   Kuipers, Ernst J ^b   Essink Bot, Marie Louise ^a   Van Leerdam, Monique E ^b   Dekker, Evelien ^a   Stoker, Jaap ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Colonoscopy; Colorectal cancer; CT Colonography; Informed decision making; Screening

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; FEMALE; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; PATIENT ATTITUDE; PATIENT DECISION MAKING; PATIENT PARTICIPATION; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); ATTITUDE TO HEALTH; COLORECTAL NEOPLASMS; CONTROLLED STUDY; DECISION MAKING; EARLY DIAGNOSIS; INFORMATION DISSEMINATION; MASS SCREENING; MIDDLE AGED; NETHERLANDS; PATIENT EDUCATION; PROCEDURES; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; REGISTER; SOCIOECONOMICS; UTILIZATION;

AGED; COLONOGRAPHY, COMPUTED TOMOGRAPHIC; COLONOSCOPY; COLORECTAL NEOPLASMS; DECISION MAKING; EARLY DETECTION OF CANCER; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFORMATION DISSEMINATION; MASS SCREENING; MIDDLE AGED; NETHERLANDS; PATIENT EDUCATION AS TOPIC; QUESTIONNAIRES; REGISTRIES; SOCIOECONOMIC FACTORS;

EID: 84877085559     PISSN: 07383991     EISSN: 18735134     Source Type: Journal    
DOI: 10.1016/j.pec.2013.01.004     Document Type: Article

References (40)

1. Statistiek CBvd. ; 2009. http://www.cbs.nl/.
2. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127:2893-2917.
3. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
4. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., et al. Cancer statistics, 2008. CA Cancer J Clin 2008, 58:71-96.
5. Heresbach D., Manfredi S., D'Halluin P.N., Bretagne J.F., Branger B. Review in depth and meta-analysis of controlled trials on colorectal cancer screening by faecal occult blood test. Eur J Gastroenterol Hepatol 2006, 18:427-433.
6. Hardcastle J.D., Chamberlain J.O., Robinson M.H., Moss S.M., Amar S.S., Balfour T.W., et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996, 348:1472-1477.
7. Mandel J.S., Church T.R., Ederer F., Bond J.H. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999, 91:434-437.
8. Jorgensen O.D., Kronborg O., Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut 2002, 50:29-32.
9. Mandel J.S., Bond J.H., Church T.R., Snover D.C., Bradley G.M., Schuman L.M., et al. Reducing mortality from colorectal cancer by screening for fecal occult blood, Minnesota Colon Cancer Control Study. N Engl J Med 1993, 328:1365-1371.
10. Winawer S.J., Zauber A.G., Ho M.N., O'Brien M.J., Gottlieb L.S., Sternberg S.S., et al. Prevention of colorectal cancer by colonoscopic polypectomy, The National Polyp Study Workgroup. N Engl J Med 1993, 329:1977-1981.
11. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
12. Atkin W.S., Edwards R., Kralj-Hans I., Wooldrage K., Hart A.R., Northover J.M., et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010, 375(9726):1624-1633.
13. Osterlie W., Solbjor M., Skolbekken J.A., Hofvind S., Saetnan A.R., Forsmo S. Challenges of informed choice in organised screening. J Med Ethics 2008, 34:e5.
14. Barratt A., Trevena L., Davey H.M., McCaffery K. Use of decision aids to support informed choices about screening. Brit Med J 2004, 329:507-510.
15. Irwig L., McCaffery K., Salkeld G., Bossuyt P. Informed choice for screening: implications for evaluation. Brit Med J 2006, 332:1148-1150.
16. Jepson R.G., Hewison J., Thompson A., Weller D. Patient perspectives on information and choice in cancer screening: a qualitative study in the UK. Soc Sci Med 2007, 65:890-899.
17. Raffle A.E. Information about screening - is it to achieve high uptake or to ensure informed choice?. Health Expect 2001, 4:92-98.
18. Marteau T.M., Dormandy E., Michie S. A measure of informed choice. Health Expect 2001, 4:99-108.
19. Michie S., Dormandy E., Marteau T.M. The multi-dimensional measure of informed choice: a validation study. Patient Educ Couns 2002, 48:87-91.
20. Bekker H., Thornton J.G., Airey C.M., Connelly J.B., Hewison J., Robinson M.B., et al. Informed decision making: an annotated bibliography and systematic review. Health Technol Assess 1999, 3:1-156.
21. Briss P., Rimer B., Reilley B., Coates R.C., Lee N.C., Mullen P., et al. Promoting informed decisions about cancer screening in communities and healthcare systems. Am J Prev Med 2004, 26:67-80.
22. Marteau T.M., Dormandy E. Facilitating informed choice in prenatal testing: how well are we doing?. Am J Med Genet 2001, 106:185-190.
23. Wald N. Information leaflets in medical screening. J Med Screen 2006, 13:109.
24. Hewitson P., Austoker J. Part 2: patient information, informed decision-making and the psycho-social impact of prostate-specific antigen testing. BJU Int 2005, 95:16-32. 15.
25. Philips Z., Avis M., Whynes D.K. Knowledge of cervical cancer and screening among women in east-central England. Int J Gynecol Cancer 2005, 15:639-645.
26. van Rijn J.C., Reitsma J.B., Stoker J., Bossuyt P.M., van Deventer S.J., Dekker E. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 2006, 101:343-350.
27. de Haan M.C., van Gelder R.E., Graser A., Bipat S., Stoker J. Diagnostic value of CT-colonography as compared to colonoscopy in an asymptomatic screening population: a meta-analysis. Eur Radiol 2011, 21:1747-1763.
28. de Wijkerslooth T.R., de Haan M.C., Stoop E.M., Deutekom M., Fockens P., Bossuyt P.M., et al. Study protocol: population screening for colorectal cancer by colonoscopy or CT colonography: a randomized controlled trial. BMC Gastroenterol 2010, 10:47.
29. Stoop E.M., de Wijkerslooth T.R., Bossuyt P.M., Stoker J., Fockens P., Kuipers E.J., et al. Face-to-face vs. telephone pre-colonoscopy consultation in colorectal cancer screening: a randomised trial. Br J Cancer 2012, 107:1051-1058.
30. Denters M.J., Deutekom M., Fockens P., Bossuyt P.M., Dekker E. Implementation of population screening for colorectal cancer by repeated fecal occult blood test in the Netherlands. BMC Gastroenterol 2009, 9:28.
31. Deutekom M., Terra M.P., Dijkgraaf M.G., Dobben A.C., Stoker J., Boeckxstaens G.E., et al. Patients' perception of tests in the assessment of faecal incontinence. Br J Radiol 2006, 79:94-100.
32. van Gelder R.E., Birnie E., Florie J., Schutter M.P., Bartelsman J.F., Snel P., et al. CT colonography and colonoscopy: assessment of patient preference in a 5-week follow-up study. Radiology 2004, 233:328-337.
33. Koller M., Aaronson N.K., Blazeby J., Bottomley A., Dewolf L., Fayers P., et al. Translation procedures for standardised quality of life questionnaires: the European Organisation for Research and Treatment of Cancer (EORTC) approach. Eur J Cancer 2007, 43:1810-1820.
34. Korfage I.J., van Ballegooijen M., Wauben B., Habbema J.D., Essink-Bot M.L. Informed choice on Pap smear still limited by lack of knowledge on the meaning of false-positive or false-negative test results. Patient Educ Couns 2011, 85:214-218.
35. Schoonen M., Wildschut H., Essink-Bot M.L., Peters I., Steegers E., de Koning H. The provision of information and informed decision-making on prenatal screening for Down syndrome: a questionnaire- and register-based survey in a non-selected population. Patient Educ Couns 2012, 87:351-359.
36. Fransen M.P., Essink-Bot M.L., Vogel I., Mackenbach J.P., Steegers E.A., Wildschut H.I. Ethnic differences in informed decision-making about prenatal screening for Down's syndrome. J Epidemiol Community Health 2010, 64:262-268.
37. van den Bergh K.A., Essink-Bot M.L., van Klaveren R.J., de Koning H.J. Informed participation in a randomised controlled trial of computed tomography screening for lung cancer. Eur Respir J 2009, 34:711-720.
38. Jepson R.G., Hewison J., Thompson A.G., Weller D. How should we measure informed choice? The case of cancer screening. J Med Ethics 2005, 31:192-196.
39. Nijs H.G., Essink-Bot M.L., DeKoning H.J., Kirkels W.J., Schröder F.H. Why do men refuse or attend population-based screening for prostate cancer?. J Public Health Med 2000, 22:312-316.
40. De Wijkerslooth T.R., de Haan M.C., Stoop E.M., Bossuyt P.M., Thomeer M., van Leerdam M.E., et al. Reasons for participation and nonparticipation in colorectal cancer screening: a randomized trial of colonoscopy and CT colonography. Am J Gastroenterol 2012, 107:1777-1783.